Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,528.52
(
2.91%
)
US TECH 100
23,134.00
(
3.59%
)
Dow Jones
46,341.51
(
2.49%
)
Brent Oil
103.14
(
-5.00%
)
Bitcoin
68,042.86
(
2.01%
)
News Focus
News Focus
Post# of 257323
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

masterlongevity

Send PM Follow Ignore
Followers 24
Posts 2597
Boards Moderated 0
Alias Born 01/07/2004

masterlongevity

Re: genisi post# 110621

Sunday, 12/12/2010 1:24:04 PM

Sunday, December 12, 2010 1:24:04 PM

Post# of 257323
this is addressed in Roche's slideset. THe PPMS population is very heterogenous. They did a post-hoc on the Rituxan data and there were some groups who responded much more favorably. they will be going after a more defined PPMS group with Ocrelizumab
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today